Compound ID | 852
EP 1350
Class: Macrolide (16-membered macrolide, tylosine derivative)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Protein synthesis inhibitors; effective against S. aureus, S. pneumoniae and H. influenzae (1) |
| Description: | Qiu Y, Jian T, Vo NH, et al. Novel 4'-O- substituted tylosin derivatives to overcome bacterial resistance. 43rd-ICAAC 2003;242 |
| Institute where first reported: | Enanta Pharmaceuticals, USA |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.